首页 > 市场调查报告书 > 製药

癌症生物标记

市场调查报告书

商品编码

1672664

癌症生物标记市场：按生物标记类型、按癌症类型、按分析技术、按最终用途、按地区

Cancer Biomarkers Market, By Biomarker Type, By Cancer Type, By Profiling Technology, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球癌症生物标记市场规模估计为 289 亿美元，预计到 2032 年将达到 676.2 亿美元，2025 年至 2032 年的复合年增长率为 12.9%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	289亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	12.90％	2032 年价值预测	676.2亿美元

数字。 2025 年各地区癌症生物标记市场占有率（%）

癌症生物标记是血液、组织或其他体液中发现的生物分子，可指示正常或异常过程、状况或疾病。这些可用于检测和监测癌症和癌症进展。近年来，癌症生物标记引起了世界各地公共和私人组织的极大关注，因为它们为癌症的诊断、分期和追踪提供了微创方法。这些生物标记也使肿瘤学家能够根据每个患者的癌症状况制定个人化治疗方案。基因分析和高通量技术的进步释放了生物标记的潜力，可以更准确地预测治疗反应和疾病进展。这对于改善全球癌症治疗具有良好的意义。

市场动态：

全球癌症生物标记市场的成长得益于全球癌症发病率的上升、精准医疗和伴同性诊断的日益普及以及生物标誌物在药物开发和核准中的应用日益增多。然而，发现、检验和商业化生物标记的高成本仍然是一个挑战。此外，技术限制和缺乏报销也抑制了市场的成长。市场正在从癌症人口众多且医疗支出不断上升的新兴国家中看到丰厚的商机。此外，透过正在进行的研究活动发现新的生物标记物，特别是针对难以治疗的癌症的生物标记物，可能会创造更多的商机。

本研究的主要特点

本报告对全球癌症生物标记市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
它还揭示了不同领域的潜在商机并解释了该市场的引人注目的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球癌症生物标记市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球癌症生物标誌物市场报告涵盖该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
透过用于分析全球癌症生物标记市场的各种策略矩阵，投资者将发现他们的决策更加容易。

bioMerieux, Inc.
INOVIQ
Bio-Rad Laboratories, Inc.
Abbott
Becton, Dickinson and Company
Merck KGaA
QIAGEN
Thermo Fisher Scientific Inc.
CENTOGENE NV
PerkinElmer Inc.
Siemens Healthineers
F. Hoffmann-la Roche Ltd
Agilent Technologies, Inc
Invitae Corporation
Myriad Genetics
Guardant Health
Illumina
FOUNDATION MEDICINE, INC.

第 11 章分析师观点

命运之轮
分析师观点
一致的机会地图

第 12 章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI175

Global Cancer Biomarkers Market is estimated to be valued at USD 28.90 Bn in 2025 and is expected to reach USD 67.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 28.90 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.90%	2032 Value Projection:	USD 67.62 Bn

Figure. Cancer Biomarkers Market Share (%), By Region 2025

Cancer biomarkers are biological molecules found in blood, tissues or other body fluids that are sign of a normal or abnormal process, or of a condition or disease. These can be used to detect and monitor cancer or cancer progression. In recent years, cancer biomarkers have gained significant attention from both global public and private organizations as these present minimally invasive ways to diagnose, stage and track cancer. Their use also enables oncologists to personalize treatments based on individual patient's cancer profiles. Advancements in genetic profiling and high-throughput technologies have unlocked the potential of biomarkers that can predict treatment responses and disease progression more accurately. This has promising implications for improving cancer care globally.

Market Dynamics:

Global cancer biomarkers market growth is driven by rising cancer prevalence worldwide, increasing popularity of precision medicine and companion diagnostics, and growing use of biomarkers in drug development as well as approvals. However, high costs associated with biomarker discovery, validation, and commercialization pose a challenge. Moreover, technical limitations and lack of reimbursements restrain the market growth. The market witnesses lucrative opportunities from emerging economies with large cancer populations and growing health expenditures. Further opportunities lie in discovery of novel biomarkers especially for hard-to-treat cancers through ongoing research efforts.

Key Features of the Study:

This report provides in-depth analysis of the global cancer biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes bioMerieux Inc., INOVIQ, Bio-Rad Laboratories Inc., Abbott, Becton Dickinson and Company, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., CENTOGENE N.V., PerkinElmer Inc., Siemens Healthineers, F. Hoffmann-la Roche Ltd, Agilent Technologies, Inc, Invitae Corporation, Myriad Genetics, Guardant Health, Illumina, and FOUNDATION MEDICINE, INC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cancer biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biomarkers market

Detailed Segmentation-

Biomarker Type:
- CA 125
- HER2
- EGFR
- CD20
- BRAF
- Calcitonin
- Others
Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Kidney Cancer
- Liver Cancer
- Head & neck Cancer
- Non-small Cell Lung Cancer
- Other Cancers
Profiling Technology:
- OMICS Technology
- Imaging Technology
- Immunoassays
- Cytogenetics
- Others
End User:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Academic Research Institutes
- Others
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- bioMerieux Inc.
- INOVIQ
- Bio-Rad Laboratories Inc.
- Abbott
- Becton Dickinson and Company
- Merck KgaA
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- CENTOGENE N.V.
- PerkinElmer Inc.
- Siemens Healthineers
- Hoffmann-la Roche Ltd
- Agilent Technologies, Inc
- Invitae Corporation
- Myriad Genetics
- Guardant Health
- Illumina
- FOUNDATION MEDICINE, INC.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Biomarker Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Profiling Technology
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Cancer Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global Cancer Biomarkers Market, By Biomarker Type, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
CA 125
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
HER2
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
EGFR
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
CD20
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
BRAF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Calcitonin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Cancer Biomarkers Market, By Cancer Type, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Kidney Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Liver Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Head & neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Non-small Cell Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Other Cancers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
OMICS Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Imaging Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Immunoassays
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Cytogenetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

8. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

9. Global Cancer Biomarkers Market, By Region, 2020 - 2032, (USD BN)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

bioMerieux, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
INOVIQ
Bio-Rad Laboratories, Inc.
Abbott
Becton, Dickinson and Company
Merck KGaA
QIAGEN
Thermo Fisher Scientific Inc.
CENTOGENE N.V.
PerkinElmer Inc.
Siemens Healthineers
F. Hoffmann-la Roche Ltd
Agilent Technologies, Inc
Invitae Corporation
Myriad Genetics
Guardant Health
Illumina
FOUNDATION MEDICINE, INC.

11. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

癌症生物标记市场：按生物标记类型、按癌症类型、按分析技术、按最终用途、按地区